X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (37) 37
surgery (34) 34
male (33) 33
index medicus (32) 32
female (27) 27
aged (26) 26
middle aged (26) 26
gastroenterology & hepatology (24) 24
pancreatic cancer (17) 17
gastroenterology and hepatology (16) 16
medicine & public health (15) 15
pancreaticoduodenectomy (15) 15
adult (14) 14
endocrinology & metabolism (14) 14
gemcitabine (12) 12
prognosis (11) 11
aged, 80 and over (10) 10
gastroenterology (10) 10
risk factors (10) 10
transplantation (10) 10
abdominal surgery (9) 9
cancer (9) 9
chemoradiotherapy (9) 9
liver (9) 9
multivariate analysis (9) 9
pancreatic neoplasms - pathology (9) 9
pancreatic neoplasms - surgery (9) 9
surgical oncology (9) 9
pancreas (8) 8
splenectomy (8) 8
survival (8) 8
adenocarcinoma (7) 7
adenocarcinoma - surgery (7) 7
chemotherapy (7) 7
health aspects (7) 7
laparoscopy (7) 7
pancreatic neoplasms - therapy (7) 7
veins & arteries (7) 7
analysis (6) 6
animals (6) 6
liver transplantation - adverse effects (6) 6
living donors (6) 6
medical prognosis (6) 6
neoadjuvant therapy (6) 6
patients (6) 6
survival rate (6) 6
treatment outcome (6) 6
tumors (6) 6
adenocarcinoma - pathology (5) 5
adenocarcinoma - therapy (5) 5
biotechnology & applied microbiology (5) 5
internal medicine (5) 5
liver cirrhosis (5) 5
medical colleges (5) 5
medicine (5) 5
medicine, research & experimental (5) 5
metastasis (5) 5
neoplasm staging (5) 5
oncology (5) 5
postoperative complications (5) 5
resection (5) 5
retrospective studies (5) 5
cancer therapies (4) 4
classification (4) 4
complications (4) 4
computed tomography (4) 4
deoxycytidine - analogs & derivatives (4) 4
diagnostic radiology (4) 4
donation of organs, tissues, etc (4) 4
dysfunction (4) 4
expression (4) 4
follow-up studies (4) 4
hematology (4) 4
hepatectomy - methods (4) 4
hepatology (4) 4
immunohistochemistry (4) 4
metaanalysis (4) 4
morphology (4) 4
mortality (4) 4
neoadjuvant chemoradiotherapy (4) 4
original (4) 4
pancreatectomy (4) 4
pancreatic ductal adenocarcinoma (4) 4
pancreaticoduodenectomy - methods (4) 4
pathology (4) 4
portal vein - pathology (4) 4
rats (4) 4
trial (4) 4
albumin (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
bile (3) 3
bile duct neoplasms - surgery (3) 3
blood (3) 3
carcinoma, hepatocellular - surgery (3) 3
carcinoma, pancreatic ductal - surgery (3) 3
carcinoma, pancreatic ductal - therapy (3) 3
chemoradiotherapy - methods (3) 3
clinical study (3) 3
cytochrome p-450 cyp3a - genetics (3) 3
diagnosis (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pancreatology, ISSN 1424-3903, 2016, Volume 16, Issue 4, pp. S11 - S11
  [...]of having discussed by pancreatic surgeons, physicians, oncologists, endoscopists, radiologists, pathologist and anatomists, anatomical criteria based... 
Endocrinology & Metabolism | Gastroenterology and Hepatology | Pancreatic cancer | Society | Veins & arteries
Journal Article
Journal of Hepato-Biliary-Pancreatic Sciences, ISSN 1868-6974, 7/2012, Volume 19, Issue 4, pp. 413 - 425
We aimed to determine the relationship between the intratumoral expression of human equilibrative nucleoside transporter (hENT1), the main gemcitabine... 
Human equilibrative nucleoside transporter-1 (hENT1) | Pathology | Survival analysis | Medicine & Public Health | Diagnostic Radiology | Gemcitabine | Pancreatic cancer | Gastroenterology | Abdominal Surgery | Internal Medicine | Surgical Oncology | Chemoradiotherapy (CRT) | human equilibrative nucleoside transporter‐1 (hENT1) | pancreatic cancer | gemcitabine | chemoradiotherapy (CRT) | survival analysis | ADJUVANT CHEMOTHERAPY | DIHYDROPYRIMIDINE DEHYDROGENASE | SURGEONS CONTRIBUTION | MINIMAL POSTOPERATIVE COMPLICATIONS | LIVER PERFUSION CHEMOTHERAPY | LONG-TERM SURVIVAL | ADENOCARCINOMA | RANDOMIZED CONTROLLED-TRIAL | THYMIDYLATE SYNTHASE EXPRESSION | FULL-DOSE GEMCITABINE | GASTROENTEROLOGY & HEPATOLOGY | Immunohistochemistry | Multivariate Analysis | Adenocarcinoma - pathology | Pancreatic Neoplasms - metabolism | Prognosis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Chemoradiotherapy, Adjuvant | Nutrition Assessment | Adenocarcinoma - metabolism | Aged, 80 and over | Adult | Female | Neoadjuvant Therapy | Pancreatic Neoplasms - mortality | CA-19-9 Antigen - blood | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Biomarkers - analysis | Thymidylate Synthase - metabolism | Treatment Outcome | Equilibrative Nucleoside Transporter 1 - metabolism | Adenocarcinoma - therapy | Survival Analysis | Aged | Neoplasm Staging | Dihydrouracil Dehydrogenase (NADP) - metabolism | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Pancreatic Neoplasms - therapy
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 03/2015, Volume 73, pp. 428 - 432
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 03/2015, Volume 73 Suppl 3, p. 428
Journal Article
Journal Article
Journal Article
Pancreatology, ISSN 1424-3903, 2016, Volume 16, Issue 4, pp. S117 - S117
  Background: Neoadjuvant chemoradiotherapy (NCRT) for pancreatic cancer is increasingly being used to improve clinical outcome and survival. 
Endocrinology & Metabolism | Gastroenterology and Hepatology | Surgery | Pancreatic cancer | Clinical outcomes
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 12/2018, Volume 18, Issue 1, pp. 619 - 7
Journal Article
Journal Article
Journal Article